Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Total 13F shares
-
19,090,905
-
Share change
-
+5,431,540
-
Total reported value
-
$4,512,539,004
-
Put/Call ratio
-
109%
-
Price per share
-
$236.40
-
Number of holders
-
287
-
Value change
-
+$1,286,111,391
-
Number of buys
-
141
-
Number of sells
-
137
Institutional Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q1 2014
As of 31 Mar 2014,
ISHARES TR - ISHARES BIOTECH (IBB) was held by
287 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,090,905 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, CITIGROUP INC, MORGAN STANLEY, BANK OF AMERICA CORP /DE/, DEUTSCHE BANK AG\, UBS AG, BARCLAYS PLC, Mirae Asset Global Investments Co., Ltd., CHURCHILL MANAGEMENT Corp, and CREDIT SUISSE AG/.
This page lists
287
institutional shareholders reporting positions in this security
for the Q1 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.